We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

SMi’s 3rd Annual Drug Discovery Chemistry

Developing your R&D pipeline with strategies to deliver small molecules

Roderick Hubbard, Senior Fellow, Vernalis Research Ltd
Darren Green, Director of Molecular Design, GSK

SMi is proud to present its 3rd Annual Drug Discovery Chemistry event, taking place on the 18th-19th March 2019.

The fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market, however, demand for novel drugs is still steadily increasing.

This year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimization of the R&D process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present, as the process is overall long, expensive and often potential drugs will fail late in clinical trials, wasting resources and ;

The event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted, and likewise, offer new drug targets for existing diseases that could potentially offer better clinical outcomes, such as within the development of cancer drugs.

Drug Discovery Chemistry will look at various developments within the field, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines, reduce their R&D cost and timelines, and ultimately, increase their medicine output for commercial success.

Event Hashtag: #SMiDrugDisChem


  • Vivek Vishnudas, Senior Vice President Drug discovery & Platform Sciences, Berg LLC
  • Tobias Gabriel, Global Head of Discovery Chemistry, Novartis
  • Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry, Biogen
  • Hasane Ratni, Expert Scientist, F Hoffmann-La Roche
  • Alexander Hillisch, Director of Medicinal Chemistry, Bayer


  • Discuss the impact of the use of novel computational techniques on R&D pipelines
  • Hear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment
  • Discover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process
  • Explore the potential of new modalities to transform therapeutics
  • Learn about current strategies to increase drug discovery success

Post conference workshop on 20 March 2019
Artificial Intelligence in Drug Discovery

Led by: Nick Camp, Consultant

CEOs, Presidents, Vice Presidents and Global Heads, Executive Directors, Vice President & Global head, Principal Scientists, Heads of Business Development, Directors of Pharma/Biotech firms.




18 Mar 2019 @ 08:30 am

19 Mar 2019 @ 05:31 pm

Duration: 1 days, 9 hours


Copthorne Tara Hotel, Central London, UK

1 Scarsdale Place


United Kingdom

Organised by

SMi Group Ltd.

Recent Publications in Chemistry

Recent Videos in Chemistry

Recent News in Chemistry

This research policy workshop will focus on how to move forward the innovation chain in the EU for bioenergy, advanced biofuels and renewable fuels, contributing to the clean energy transformation in energy and transport, in line with the Strategic Development Goals and the EU Communication “Clean Planet for All”. For this purpose, the workshop will identify the research and innovation needs, the strategy and the roadmap for bioenergy, biofuels and renewable fuels to make the European industrial energy and transport sectors economically and environmentally sustainable, secure and competitive in the global markets. The agenda will focus on the value chains of advanced biofuels, renewable fuels, intermediate bioenergy carriers and biomass-based cogeneration of heat and power. The entire innovation sequence will be discussed, from breakthrough technologies to applied research and demonstration, pre-commercial scale financing and market up-take support measures. Results from the entire portfolio of around 60 projects supported under the European Union’s Framework Programme Horizon 2020 – Secure, clean and efficient energy challenge will feed into the discussion. The views of the engaged EU Member States and of research and industrial stakeholders will be an important additional contribution, to identify non-technological support pathways through new tools, research concepts, the mobilization of national actions, private engagement and financing mechanisms. The workshop will then report on the progress of the innovation chains, the effectiveness of pushing innovative solutions into the market and their broader penetration into the energy and transport mix. Policy recommendations based on project results, the Member States’ interests and plans, as well as the views of the stakeholders, will also be collected and reported.

@http://ec.europa.eu/research/index.cfm?pg=events&eventcode=3AED3292-ED14-0D64-22761AA7F9CB5D9B - 21 Mar 2019 10:11

See here https://t.co/7o0KV6mW9L how you can get your #eID project co-financed #ConnectingEurope https://t.co/RtFK3YGPDU

@inea_eu - 21 Mar 2019 09:35

The @EU_Commission is working to improve prevention, diagnosis & treatment of the #downsyndrome. The starting point… https://t.co/dwdPVJVRJY

@EU_ScienceHub - 21 Mar 2019 09:04

Recent Speakers in Chemistry